We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blueberries Shown to Pack Big Heart Health Benefits

By LabMedica International staff writers
Posted on 20 Jan 2015
Print article
Just one cup of blueberries per day could be the enough to reduce blood pressure and arterial stiffness, both of which are linked with cardiovascular disease.

“Our findings suggest that regular consumption of blueberries could potentially delay the progression of prehypertension to hypertension, therefore reducing cardiovascular disease risk,” said Dr. Sarah A. Johnson, assistant director of the Center for Advancing Exercise and Nutrition Research on Aging (CAENRA), and postdoctoral fellow in the department of nutrition, food and exercise sciences at Florida State University (FSU; Tallahassee, USA).

Dr. Johnson and nutrition and exercise scientists colleagues at FSU are the authors of a new study, which was published online January 7, 2015, in the Journal of the Academy of Nutrition and Dietetics. Dr. Johnson stated she is interested in looking at how functional foods—foodstuffs that have a positive impact on health beyond essential nutrition—can prevent and reverse negative health outcomes, especially for postmenopausal women. “Cardiovascular disease is the leading cause of death in the United States,” she said. “Once women go through menopause, this puts them at an even greater risk for it. Our findings suggest that the addition of a single food, blueberries, to the diet may mitigate the negative cardiovascular effects that often occur as a result of menopause.”

Over an eight-week period, 48 postmenopausal women with pre- and stage-1 hypertension were randomly assigned to receive either 22 g of freeze-dried blueberry powder (one cup of fresh blueberries) or 22 g of a placebo powder. In the meantime, participants kept on their normal diet and exercise routines.

At the start of the study, the team took participants’ blood pressure and measured their arterial stiffness and specific blood biomarkers. At the end of the eight weeks, participants receiving the blueberry powder on average had a 7 mmHg (5.1%) decrease in systolic blood pressure, which is the top number in the blood pressure reading that measures the pressure in the arteries when the heart beats. They also saw a 5 mmHg (6.3%) reduction in diastolic blood pressure, or the bottom number measuring the pressure in the arteries between heartbeats. Moreover, study participants in the blueberry-treated group had an average reduction of 97 cm/second (6.5%) in arterial stiffness.

The investigators also discovered that nitric oxide, a blood biomarker known to be involved in the widening of blood vessels, increased by 68.5%. That is important, according to Dr. Johnson, because arterial stiffness and the narrowing of blood vessels are both a part of hypertension. This rise in nitric oxide helps explain the reductions in blood pressure.

Earlier research on blueberries have shown positive effects on cardiovascular risk factors including blood pressure, but they all included large amounts of blueberry powder consumption, anywhere from 50–250 g. In the case of 250 g, that would mean more than 11 cups of fresh blueberries, which may not be realistic for individuals to eat on a regular basis.

Dr. Johnson reported that future studies will consider other dosages of blueberries, longer intervention periods, and other sample populations.

Related Links:

Florida State University


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Unit-Dose Packaging solution
HLX
New
Silver Member
Static Concentrator
BJP 10
New
Gold Member
Anti-CCP Kit
BioPlex 2200 Anti-CCP

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.